TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion October 5, 2012
TCL Archive In Brief: Some Cancer Centers Funded At “Recommended” Levels For Fiscal 1981, But There Was A Catch October 30, 1981
TCL Archive Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says April 20, 1990